Roger Garceau - 01 Jan 2022 Form 3 Insider Report for Entera Bio Ltd. (ENTX)

Role
Director
Signature
/s/ Dana Yaacov-Garbeli, Attorney-in-fact
Issuer symbol
ENTX
Transactions as of
01 Jan 2022
Net transactions value
$0
Form type
3
Filing time
11 Jan 2022, 15:01:41 UTC
Previous filing
10 Jun 2021
Next filing
09 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ENTX Ordinary Shares, par value NIS 0.0000769 per share 4,940 01 Jan 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ENTX Stock Option (right to buy) 01 Jan 2022 Ordinary Shares, par value NIS 0.0000769 per share 147,290 $3.69 Direct
holding ENTX Stock Option (right to buy) 01 Jan 2022 Ordinary Shares, par value NIS 0.0000769 per share 209,040 $6.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vested on a monthly basis over a three-year period that commenced January 1, 2017.

Remarks:

See Exhibit 24.1 - Power of Attorney